| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C15H19NO3 |
| Molar mass | 261.321 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone (MDPBP) is astimulant of thecathinone class developed in the 1960s,[1][2] which has been reported as a noveldesigner drug.[3][4] MDPBP is sometimes sold under the name "NRG-1" as a mixture with other cathinone derivatives, includingflephedrone,pentylone,MαPPP and its higher homologueMDPV.[5] As with othercathinones, MDPBP has been shown to have reinforcing effects in rats.[6]
The main metabolic steps are thought to be demethylenation followed by methylation of one hydroxy group, aromatic and side chain hydroxylation, oxidation of the pyrrolidine ring to the corresponding lactam as well as ring opening to the corresponding carboxylic acid. CYP2C19 and CYP2D6 have been identified as the isoenzymes mainly responsible for demethylenation.[7]
As of October 2015[update] MDPBP is a controlled substance in Poland and China.[8]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |